[Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].

Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Juan Ricardo Márquez, Fabián Eduardo Puentes-Manosalva, Fernando Sarmiento, Rafael García-Duperly, Melquisedec Vargas, Gustavo Reyes, Carolina Samper, Manuel Barreiro-de-Acosta
{"title":"[Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].","authors":"Viviana Parra-Izquierdo,&nbsp;Juan Sebastián Frías-Ordoñez,&nbsp;Juan Ricardo Márquez,&nbsp;Fabián Eduardo Puentes-Manosalva,&nbsp;Fernando Sarmiento,&nbsp;Rafael García-Duperly,&nbsp;Melquisedec Vargas,&nbsp;Gustavo Reyes,&nbsp;Carolina Samper,&nbsp;Manuel Barreiro-de-Acosta","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In Colombia there are no data about perception of quality of life (QoL) in inflammatory bowel disease (IBD). The aim of this study was to determine the perception of QoL by means of the IBDQ-32 questionnaire in patients with IBD from a sample of patients from different referral centers. We carried out a cross-sectional study in adults with IBD in clinical remission, in outpatient follow-up, in 3 institutions in different cities, between June 2022 and November 2022, eligible subjects were identified, information was collected on different dates, about socio-demographic and clinical aspects, and the IBDQ-32 questionnaire was evaluated on one occasion. Descriptive and analytical analysis of the variables evaluated was performed. 80 patients, 70% women, mean age 38.5(range 18-72; SD 13.25) years. 67.5% ulcerative colitis (UC), 32.5% Crohn's disease (CD). Moderate QoL involvement (median 150 points, interquartile range118.3-181.5) was found in IBD, in UC median 151 (interquartile range120-174.75) points, while in CD 133 (interquartile range106.25-186.25) points. There was greater involvement in the systemic domain, with median 21 (interquartile range 15.8-27) points, and 18.5 (interquartile range 12.8-25.3) points, for UC and CD, respectively. The least affected corresponded to the digestive domain and social function, in median UC 48.5 (interquartile range 40-58.3), and 27(interquartile range 20.8-33); in median CD 43 (interquartile range 35.5-61.75) and 24.5(interquartile range 18-32.5), respectively. No statistically significant differences were found. This study provides unique information about QoL of patients with IBD in Colombia. It is necessary to continue reinforcing the accompaniment, support, and education of patients with IBD.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In Colombia there are no data about perception of quality of life (QoL) in inflammatory bowel disease (IBD). The aim of this study was to determine the perception of QoL by means of the IBDQ-32 questionnaire in patients with IBD from a sample of patients from different referral centers. We carried out a cross-sectional study in adults with IBD in clinical remission, in outpatient follow-up, in 3 institutions in different cities, between June 2022 and November 2022, eligible subjects were identified, information was collected on different dates, about socio-demographic and clinical aspects, and the IBDQ-32 questionnaire was evaluated on one occasion. Descriptive and analytical analysis of the variables evaluated was performed. 80 patients, 70% women, mean age 38.5(range 18-72; SD 13.25) years. 67.5% ulcerative colitis (UC), 32.5% Crohn's disease (CD). Moderate QoL involvement (median 150 points, interquartile range118.3-181.5) was found in IBD, in UC median 151 (interquartile range120-174.75) points, while in CD 133 (interquartile range106.25-186.25) points. There was greater involvement in the systemic domain, with median 21 (interquartile range 15.8-27) points, and 18.5 (interquartile range 12.8-25.3) points, for UC and CD, respectively. The least affected corresponded to the digestive domain and social function, in median UC 48.5 (interquartile range 40-58.3), and 27(interquartile range 20.8-33); in median CD 43 (interquartile range 35.5-61.75) and 24.5(interquartile range 18-32.5), respectively. No statistically significant differences were found. This study provides unique information about QoL of patients with IBD in Colombia. It is necessary to continue reinforcing the accompaniment, support, and education of patients with IBD.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[炎症性肠病缓解期哥伦比亚患者IBDQ-32的健康相关生活质量:一项横断面研究]。
在哥伦比亚,没有关于炎症性肠病(IBD)的生活质量(QoL)感知的数据。本研究的目的是通过IBDQ-32问卷从不同转诊中心的患者样本中确定IBD患者的生活质量感知。我们在2022年6月至2022年11月期间,在不同城市的3个机构对临床缓解期、门诊随访期的IBD成人进行了一项横断面研究,确定了符合条件的受试者,在不同日期收集了有关社会人口统计学和临床方面的信息,并对IBDQ-32问卷进行了一次评估。对评估的变量进行了描述性和分析性分析。80名患者,70%为女性,平均年龄38.5岁(18-72岁;标准差13.25岁)。67.5%溃疡性结肠炎(UC)、32.5%克罗恩病(CD)。IBD、UC中位151(四分位数范围120-174.75)点和CD 133(四分位范围106.25-186.25)点的生活质量中度受累(中位150分,四分位数间距118.3-181.5)。系统域的参与程度更高,UC和CD的中位数分别为21(四分位间距15.8-27)点和18.5(四分位数间距12.8-25.3)点。受影响最小的是消化系统和社会功能,中位UC为48.5(四分位间距40-58.3)和27(四分位距20.8-33);中位数CD 43(四分位间距35.5-61.75)和24.5(四分位数间距18-32.5)。没有发现统计学上的显著差异。这项研究提供了关于哥伦比亚IBD患者生活质量的独特信息。有必要继续加强IBD患者的陪伴、支持和教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
49
期刊介绍: La REVISTA DE GASTROENTEROLOGíA DEL PERÚ, es la publicación oficial de la Sociedad de Gastroenterología del Perú que publica artículos originales, artículos de revisión, reporte de casos, cartas e información general de la especialidad; dirigido a los profesionales de la salud con especial interés en la gastroenterología. La Revista de Gastroenterología del Perú es una publicación de periodicidad trimestral y tiene como objetivo la publicación de artículos científicos inéditos en el campo de la gastroenterología, proporcionando información actualizada y relevante de la especialidad y áreas afines. La Revista de Gastroenterología del Perú publica artículos en dos idiomas, español e inglés, a texto completo en la versión impresa yelectrónica. Los artículos científicos son sometidos a revisores o árbitros nacionales e internacionales, especialistas que opinan bajo la modalidad de doble ciego y de manera anónima sobre la calidad y validez de los mismos. El número de revisores depende del tipo de artículo, dos revisores como mínimo para artículos originales y uno como mínimo para otros tipos de artículos.
期刊最新文献
[Commun salt application as a treatment for percutaneous endoscopic gastrostomy periostomal granuloma]. [Conventional colonoscopy vs. cap-assisted colonoscopy: there are differences in colonoscopy performance?] [Efficaccy of probiotic in the treatment of small intestinal bacterial overgrowth. Systematic review and meta-analysis]. [Evaluation of the usability of patients attended in gastrointestinal telemedicine postpandemic at University clinic]. [Procedure, reading and interpretation of capsule endoscopy].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1